Pharmacoepidemiological profile of patients with mellitus type 1 diabetes

Authors

DOI:

https://doi.org/10.33448/rsd-v9i5.3361

Keywords:

Diabetes; Insulin; Youth.

Abstract

Diabetes Mellitus is an important health problem that affects millions of people in Brazil and worldwide. The type Diabetes Mellitus 1 is a predominantly autoimmune pathology, where pancreatic ß cells are progressively destroyed, resulting in absolute insulin deficiency. This study aims to quantitatively describe the pharmacoepidemiological profile of patients with DM1 treated by the specialized pharmaceutical assistance component (CEAF) in Piauí. The research was carried out at CEAF / SESAPI, through a data survey carried out through analysis of protocols and records of patients with DM1 attended at this location from January to July 2017. The present study showed the patients with DM1 attended by CEAF / SESAPI, are predominantly teenagers and young adults, from the state capital. The survey showed that only 37% of DM1 patients have good glycemic control, showing a warning sign. It was shown that among the acute complications caused by DM1, hypoglycemia was the most frequent, in relation to chronic complications, 28% already had the same, with microalbuminuria being the most frequent. The prescriptions contained in the patients' protocols were analyzed and it was found that 42% of them were outside the requirements of the law, which can hinder the development of pharmacological therapy. Thus, it is possible to observe the importance of analyzing the pharmacoepidemiological profile of patients with DM1, as a relevant data for the discussion on the use of medications for DM1 patients of the CEAF / SESAPI specific to diabetics.

Author Biography

Gisele Lopes Cavalcante, Mestre em Ciências Farmacêuticas - UFPI.

Departamento de farmacia UFPI

References

Aguiar, G., da Silva, L. A., & Ferreira, M. A. M. (2006). Ilegibilidade e ausência de informação nas prescrições médicas: fatores de risco relacionados a erros de medicação. Revista Brasileira em Promoção da Saúde, 19(2), 0.

Alves, D., Kachan, B., Carboni, C., Mariano, P., Calmeiro, M., & Silva, R. (2016). LADA numa Unidade Integrada de Diabetes. Medicina Interna, 23(4), 22-25.

American Diabetes Association. (2019). 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes—2019. Diabetes care, 42(Supplement 1), S34-S45.

Animaw, W., & Seyoum, Y. (2017). Increasing prevalence of diabetes mellitus in a developing country and its related factors. PloS one, 12(11).

Cheng, A. Y., & Lau, D. C. (2013). The Canadian Diabetes Association 2013 clinical practice guidelines—raising the bar and setting higher standards!. Canadian journal of diabetes, 37(3), 137-138.

Chien, S. C., Larson, E., Nakamura, N., & Lin, S. J. (2007). Self-care problems of adolescents with type 1 diabetes in southern Taiwan. Journal Of Pediatric Nursing, 22(5), 404-409.

Davies, M. J., Gross, J. L., Ono, Y., Sasaki, T., Bantwal, G., Gall, M. A., & BEGIN BB T1 study group. (2014). Efficacy and safety of insulin degludec given as part of basal–bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26‐week randomized, open‐label, treat‐to‐target non‐inferiority trial. Diabetes, Obesity and Metabolism, 16(10), 922-930.

Delamater, A. M., de Wit, M., McDarby, V., Malik, J., & Acerini, C. L. (2014). Psychological care of children and adolescents with type 1 diabetes. Pediatric diabetes, 15(S20), 232-244.

Dos Santos, J. P., Vieira, L. D. M. C., Dos Santos Pionório, M. E., & Silva, I. P. (2019). Diabetes mellitus in Brazil: risk factors, classification and complications. International Journal of Medical Reviews and Case Reports, 3(11), 744-747.

Edlavitch, SA (2018). Farmacoepidemiologia. Routledge.

Eliaschewitz, F. G., Franco, D. R., Mares-Guia, T. R., Noronha, I. L., Labriola, L., & Sogayar, M. C. (2009). Transplante de ilhotas na prática clínica: estado atual e perspectivas. Arquivos Brasileiros de Endocrinologia & Metabologia, 53(1), 15-23.

Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D.E., & Geiss, L. (2014). Changes in diabetes-related complications in the United States, 1990–2010. New England Journal of Medicine, 370(16), 1514-1523.

Hendrieckx, C., Hagger, V., Jenkins, A., Skinner, T. C., Pouwer, F., & Speight, J. (2017). Severe hypoglycemia, impaired awareness of hypoglycemia, and self-monitoring in adults with type 1 diabetes: Results from Diabetes MILES—Australia. Journal of Diabetes and its Complications, 31(3), 577-582.

Litwak, L. E. (2018). Nuevos análogos de insulina. Su utilización en pacientes con enfermedad renal crónica. MEDICINA (Buenos Aires), 78(1), 59.

Lopes, C. L., Pinheiro, P. P., Barberena, L. S., & Eckert, G. U. (2017). Cetoacidose diabética em uma unidade de terapia intensiva pediátrica. Jornal de Pediatria, 93(2), 179-184.

Miculis, C. P., Mascarenhas, L. P., Boguszewski, M. C., & de Campos, W. (2010). Physical activity in children with type 1 diabetes. Jornal de pediatria, 86(4), 271-278.

Milech, A., Angelucci, A. P., Golbert, A., Matheus, A., Carrilho, A. J., & Ramalho, A. C. (2016). Diretrizes da sociedade brasileira de diabetes (2015-2016). São Paulo: AC Farmacêutica.

Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., D. Cavan, J.E., Shaw, L.E., & Makaroff, L. E. (2017). IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40-50.

Pereira, A.S. et al. (2018). Metodologia da pesquisa científica. [e-book]. Santa Maria. Ed. UAB/NTE/UFSM. Disponível em: https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1. Acesso em: 30 março 2020.

Strom, B. L., Kimmel, S. E., & Hennessy, S. (Eds.). (2012). Pharmacoepidemiology. John Wiley & Sons.

Published

04/04/2020

How to Cite

CAVALCANTE, G. L.; MOURA, M. C. L. de; LAGO, A. F. V. D.; LIMA, J. V. de O.; COSTA, M. H. de A. da; GONÇALVES, J. N. de A.; SILVA, H. R. da; BONFIM, K. L. de F.; BATISTA, M. de K. P.; ARAÚJO, J. L. Pharmacoepidemiological profile of patients with mellitus type 1 diabetes. Research, Society and Development, [S. l.], v. 9, n. 5, p. e184953361, 2020. DOI: 10.33448/rsd-v9i5.3361. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/3361. Acesso em: 21 dec. 2024.

Issue

Section

Health Sciences